Abstract

Type 1 diabetes is a disease involving autoimmune destruction of pancreatic beta cells in genetically predisposed individuals. Identifying factors that trigger initiation and progression of autoimmunity may provide opportunities for directed prophylactic and therapeutic measures to prevent and/or treat type 1 diabetes. The human intestinal microbiome is a complex, symbiotic ecological community that influences human health and development, including the development and maintenance of the human immune system. The role of the intestinal microbiome in autoimmunity has garnered significant attention, and evidence suggests a particular role for intestinal microbiome alterations in autoimmune disease development, including type 1 diabetes. This review will examine the role of the intestinal microbiome in the development and function of the immune system and how this relates to the development of autoimmunity. Data from animal and human studies linking alterations in the intestinal microbiome and intestinal integrity with type 1 diabetes will be closely examined. Finally, we will examine the interactions between the intestinal microbiome and dietary exposures and how these interactions may further influence autoimmunity and type 1 diabetes development.

Original languageEnglish (US)
Pages (from-to)103-118
Number of pages16
JournalAnnals of the New York Academy of Sciences
Volume1243
Issue number1
DOIs
StatePublished - Dec 2011

Fingerprint

Medical problems
Type 1 Diabetes Mellitus
Autoimmunity
Immune system
Human Development
Autoimmune Diseases
Immune System
Biota
Peptide Initiation Factors
Microbiota
Insulin-Secreting Cells
Animals
Gastrointestinal Microbiome
Diabetes
Mouse
Health

Keywords

  • Gliadin
  • Intestine, microbiome
  • Type 1 diabetes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Cite this

Type 1 diabetes : Role of intestinal microbiome in humans and mice. / Boerner, Brian P; Sarvetnick, Nora E.

In: Annals of the New York Academy of Sciences, Vol. 1243, No. 1, 12.2011, p. 103-118.

Research output: Contribution to journalReview article

@article{88dd8a49b8d248b28dd9854e8d4edd61,
title = "Type 1 diabetes: Role of intestinal microbiome in humans and mice",
abstract = "Type 1 diabetes is a disease involving autoimmune destruction of pancreatic beta cells in genetically predisposed individuals. Identifying factors that trigger initiation and progression of autoimmunity may provide opportunities for directed prophylactic and therapeutic measures to prevent and/or treat type 1 diabetes. The human intestinal microbiome is a complex, symbiotic ecological community that influences human health and development, including the development and maintenance of the human immune system. The role of the intestinal microbiome in autoimmunity has garnered significant attention, and evidence suggests a particular role for intestinal microbiome alterations in autoimmune disease development, including type 1 diabetes. This review will examine the role of the intestinal microbiome in the development and function of the immune system and how this relates to the development of autoimmunity. Data from animal and human studies linking alterations in the intestinal microbiome and intestinal integrity with type 1 diabetes will be closely examined. Finally, we will examine the interactions between the intestinal microbiome and dietary exposures and how these interactions may further influence autoimmunity and type 1 diabetes development.",
keywords = "Gliadin, Intestine, microbiome, Type 1 diabetes",
author = "Boerner, {Brian P} and Sarvetnick, {Nora E}",
year = "2011",
month = "12",
doi = "10.1111/j.1749-6632.2011.06340.x",
language = "English (US)",
volume = "1243",
pages = "103--118",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Type 1 diabetes

T2 - Role of intestinal microbiome in humans and mice

AU - Boerner, Brian P

AU - Sarvetnick, Nora E

PY - 2011/12

Y1 - 2011/12

N2 - Type 1 diabetes is a disease involving autoimmune destruction of pancreatic beta cells in genetically predisposed individuals. Identifying factors that trigger initiation and progression of autoimmunity may provide opportunities for directed prophylactic and therapeutic measures to prevent and/or treat type 1 diabetes. The human intestinal microbiome is a complex, symbiotic ecological community that influences human health and development, including the development and maintenance of the human immune system. The role of the intestinal microbiome in autoimmunity has garnered significant attention, and evidence suggests a particular role for intestinal microbiome alterations in autoimmune disease development, including type 1 diabetes. This review will examine the role of the intestinal microbiome in the development and function of the immune system and how this relates to the development of autoimmunity. Data from animal and human studies linking alterations in the intestinal microbiome and intestinal integrity with type 1 diabetes will be closely examined. Finally, we will examine the interactions between the intestinal microbiome and dietary exposures and how these interactions may further influence autoimmunity and type 1 diabetes development.

AB - Type 1 diabetes is a disease involving autoimmune destruction of pancreatic beta cells in genetically predisposed individuals. Identifying factors that trigger initiation and progression of autoimmunity may provide opportunities for directed prophylactic and therapeutic measures to prevent and/or treat type 1 diabetes. The human intestinal microbiome is a complex, symbiotic ecological community that influences human health and development, including the development and maintenance of the human immune system. The role of the intestinal microbiome in autoimmunity has garnered significant attention, and evidence suggests a particular role for intestinal microbiome alterations in autoimmune disease development, including type 1 diabetes. This review will examine the role of the intestinal microbiome in the development and function of the immune system and how this relates to the development of autoimmunity. Data from animal and human studies linking alterations in the intestinal microbiome and intestinal integrity with type 1 diabetes will be closely examined. Finally, we will examine the interactions between the intestinal microbiome and dietary exposures and how these interactions may further influence autoimmunity and type 1 diabetes development.

KW - Gliadin

KW - Intestine, microbiome

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84255178422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84255178422&partnerID=8YFLogxK

U2 - 10.1111/j.1749-6632.2011.06340.x

DO - 10.1111/j.1749-6632.2011.06340.x

M3 - Review article

C2 - 22211896

AN - SCOPUS:84255178422

VL - 1243

SP - 103

EP - 118

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

IS - 1

ER -